Myriad Sues Third Firm, BioReference's GeneDx, Alleging BRCA1/2 Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics and other parties are suing BioReference Laboratories' GeneDx alleging infringement of patents covering BRCA1 and BRCA2 genes.

Along with Myriad, the University of Utah Research Foundation, the trustees of the University of Pennsylvania, Toronto's Hospital for Sick Children, and Endorecherche are plaintiffs in the lawsuit, which was filed last week in US District Court for the District of Utah, Central Division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.